Citation only
via OpenAlex
Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
QJM · 2008 · ▲ 27 citations
Abstract
BACKGROUND: Metabolic syndrome (MetS) is used as a clinical tool to identify individuals at risk of cardiovascular disease (CVD) but its clinical value in the management of type 2 diabetes mellitus (T2DM) remains uncertain. AIM: To determine the prevalence and clinical usefulness of MetS among patients with T2DM attending diabetes clinics in a large teaching hospital. DESIGN: Prospective observational study. METHODS: Prevalence of MetS was determined by using International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) definitions in relation to age, sex, diabetes duration and history of CVD. RESULTS: A total of 390 patients were included in this study. Both IDF and NCEP-ATPIII definitions identified high prevalence of MetS in male and female patients (IDF: male vs. female, 91.7 vs. 94.8% and NCEP-ATPIII: male vs. female, 87.6 vs. 94.2%) regardless of age (below vs. above 40 yrs, approximately 70-75 vs. approximately 90-95% with both definitions), diabetes duration (below vs. above 5 yrs, approximately 85-90 vs. 90-95% with both definitions) and history of CVD (without vs. with CVD, approximately 90 vs. approximately 95% with both definitions). Central obesity was common reflected by mean waist circumference of approximately 113 cm regardless of age and gender. Among those who did not have IDF-defined MetS, approximately 60% had at least two CVD risk factors. Both definitions similarly classified approximately 94% of the patients as either having or not having MetS. DISCUSSION: Both definitions can be used interchangeably to diagnose MetS. However, the clinical usefulness of MetS is debatable given the very high prevalence of this condition in T2DM.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/qjmed/hcn034
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Song, S.H., & Hardisty, C.A. (2008). Diagnosing metabolic syndrome in type 2 diabetes: does it matter?. <em>QJM</em>. https://doi.org/10.1093/qjmed/hcn034
Vancouver
Song SH, Hardisty CA. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?. QJM. 2008. doi:10.1093/qjmed/hcn034.
BibTeX
@article{soon2008Diagno,
title = {Diagnosing metabolic syndrome in type 2 diabetes: does it matter?},
author = {Soon H Song and Colin A Hardisty},
journal = {QJM},
year = {2008},
doi = {10.1093/qjmed/hcn034},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Nutritional Science and Vitaminology 2016
Open access · OA
Vitamin D Deficiency in Relation to the Risk of Metabolic Syndrome in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus
International Journal of Advanced Research in Medicine 2023
Open access · OA
Assessment of metabolic syndrome in type 2 diabetes mellitus
British Journal Of Nutrition 2013
Open access · OA
Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial
Gerontology 2009
Open access · OA
Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus
Circulation 2005
Citation only
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Cardiovascular Journal 1970
Open access · OA